Oral Realgar-Indigo Naturalis Formula Versus Intravenous Arsenic Trioxide for Non-High-Risk Patients with Acute Promyelocytic Leukemia: Interim Results of a Multicenter Randomized Controlled Trial APL16
Year: 2022
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Blood
Authors: Huaiyu Wang, Shu Chen, Xiaojuan Zhang, Xinhua Lu, Sha Gong, David Wald, Haitao Zhang, Jing Li
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4310162912
